NO307689B1 - Anvendelse av et antimikrobielt middel - Google Patents

Anvendelse av et antimikrobielt middel

Info

Publication number
NO307689B1
NO307689B1 NO932947A NO932947A NO307689B1 NO 307689 B1 NO307689 B1 NO 307689B1 NO 932947 A NO932947 A NO 932947A NO 932947 A NO932947 A NO 932947A NO 307689 B1 NO307689 B1 NO 307689B1
Authority
NO
Norway
Prior art keywords
campylobacter pylori
disease caused
antimicrobial agent
preventing
bacterium
Prior art date
Application number
NO932947A
Other languages
English (en)
Norwegian (no)
Other versions
NO932947L (no
NO932947D0 (no
Inventor
Masaru Sato
Shigeru Souda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO932947D0 publication Critical patent/NO932947D0/no
Publication of NO932947L publication Critical patent/NO932947L/no
Publication of NO307689B1 publication Critical patent/NO307689B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO932947A 1992-08-21 1993-08-19 Anvendelse av et antimikrobielt middel NO307689B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24404292 1992-08-21

Publications (3)

Publication Number Publication Date
NO932947D0 NO932947D0 (no) 1993-08-19
NO932947L NO932947L (no) 1994-02-22
NO307689B1 true NO307689B1 (no) 2000-05-15

Family

ID=17112856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932947A NO307689B1 (no) 1992-08-21 1993-08-19 Anvendelse av et antimikrobielt middel

Country Status (10)

Country Link
US (1) US5916904A (fr)
EP (1) EP0585722B1 (fr)
AT (1) ATE137969T1 (fr)
CA (1) CA2104531C (fr)
DE (1) DE69302646T2 (fr)
DK (1) DK0585722T3 (fr)
ES (1) ES2087623T3 (fr)
FI (1) FI933681A7 (fr)
GR (1) GR3019917T3 (fr)
NO (1) NO307689B1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
CA2317439A1 (fr) 1998-01-14 1999-07-22 Wayne J. Brouillette Procede de synthese et de criblage d'inhibiteurs d'enzyme synthetase nad bacterienne, composes a base de cette enzyme et procedes de traitement des infections bacteriennes et microbiennes au moyen d'inhibiteurs de ladite enzyme
US6861448B2 (en) 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
EP1109805B1 (fr) * 1998-08-25 2003-12-17 The Uab Research Foundation Inhibiteurs de la nad synthetase bacterienne
US6174902B1 (en) 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
JP4355703B2 (ja) * 2003-03-13 2009-11-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 歯ぎしりの予防剤または治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
JPH0348680A (ja) * 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
EP0585722B1 (fr) 1996-05-15
CA2104531C (fr) 1999-01-05
DE69302646D1 (de) 1996-06-20
NO932947L (no) 1994-02-22
FI933681L (fi) 1994-02-22
FI933681A7 (fi) 1994-02-22
ES2087623T3 (es) 1996-07-16
CA2104531A1 (fr) 1994-02-22
FI933681A0 (fi) 1993-08-20
DK0585722T3 (da) 1996-08-05
EP0585722A1 (fr) 1994-03-09
US5916904A (en) 1999-06-29
DE69302646T2 (de) 1996-10-31
ATE137969T1 (de) 1996-06-15
GR3019917T3 (en) 1996-08-31
NO932947D0 (no) 1993-08-19

Similar Documents

Publication Publication Date Title
NO307689B1 (no) Anvendelse av et antimikrobielt middel
OA09334A (fr) "Dérivés d'acides aminés".
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
FI102896B1 (fi) Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
EP0342587A3 (fr) Thiénotriazolodiazépines et leur applications pharmaceutiques
AU4175893A (en) Treatment of inflammatory bowel disease
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
KR880007070A (ko) 백내장 치료용 약학 조성물
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
FI923662A0 (fi) Terapeutiska medel.
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
NO910033D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
DE69223455D1 (de) WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ES2134441T3 (es) Benzonitrilos terapeuticos.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
NO941478L (no) Ny forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Legal Events

Date Code Title Description
MK1K Patent expired